An active pharmaceutical ingredient (API) is a drug or combination of drugs used in a finished pharmaceutical product which becomes the biologically active ingredient within the drug product intended for the diagnosis, treatment, or prevention of a disease.

The increasing incidence of chronic diseases growing importance of generics and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market.

The global active pharmaceutical ingredient market is estimated to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period.

Last year`s exhibitors from this sector: 28%